甘舒霖30R联合阿卡波糖治疗老年糖尿病患者44例  

Clinical effect analysis of Ganshulin 30R combined with acarbose in the treatment of elderly patients with diabetes mellitus

作　　者：赵艳红 Zhao Yanhong(Cang Ling Township Hospital of Chuxiong City in Yunnan Province 675004)

机构地区：[1]云南省楚雄市苍岭镇卫生院,675004

出　　处：《中国社区医师》2018年第35期63-63,65,共2页Chinese Community Doctors

摘　　要：目的:探讨混合重组人胰岛素注射液(甘舒霖30R)联合阿卡波糖治疗老年糖尿病患者的临床疗效。方法:收治老年糖尿病患者88例,随机分为两组,每组各44例。对照组给予甘舒霖30R治疗,观察组给予甘舒霖30R联合阿卡波糖治疗,比较两组治疗前后空腹血糖(FPG)、餐后2 h血糖(2hPG)、每日胰岛素用量以及不良反应情况。结果:观察组治疗后FPG、2hPG水平低于对照组,每日胰岛素用量明显低于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率显著低于对照组,差异有统计学意义(P<0.05)。结论:甘舒霖30R联合阿卡波糖可以显著降低老年糖尿病患者的血糖水平,减少胰岛素的用量。Objective:To investigate the clinical effect of recombinant human insulin injection(Ganshulin 30R)combined with acarbose in the treatment of elderly patients with diabetes mellitus.Methods:88 cases of elderly patients with diabetes mellitus were divided into two groups randomly.The control group was treated with Ganshulin30R,and the observation group was treated with Ganshulin 30 R combined with acarbose,the fasting blood glucose(FPG),2-hour postprandial blood glucose(2hPG),daily insulin dosage and adverse reactions were compared between the two groups before and after treatment.Results:After treatment,the levels of FPG and2h PG in the observation group were lower than those in the control group,and the daily insulin dosage was significantly lower than those in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was significantly lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion:Ganshulin30R combined with acarbose could reduce the blood glucose level significantly and insulin dosage in elderly patients with diabetes mellitus.

关 键 词：混合重组人胰岛素注射液 阿卡波糖 糖尿病 临床疗效 

分 类 号：R587.1[医药卫生—内分泌]